1. Home
  2. MHLD vs NKTR Comparison

MHLD vs NKTR Comparison

Compare MHLD & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MHLD
  • NKTR
  • Stock Information
  • Founded
  • MHLD 2007
  • NKTR 1990
  • Country
  • MHLD Bermuda
  • NKTR United States
  • Employees
  • MHLD N/A
  • NKTR N/A
  • Industry
  • MHLD Property-Casualty Insurers
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • MHLD Finance
  • NKTR Health Care
  • Exchange
  • MHLD Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • MHLD 174.7M
  • NKTR 238.7M
  • IPO Year
  • MHLD 2008
  • NKTR 1994
  • Fundamental
  • Price
  • MHLD $1.81
  • NKTR $1.45
  • Analyst Decision
  • MHLD
  • NKTR Buy
  • Analyst Count
  • MHLD 0
  • NKTR 4
  • Target Price
  • MHLD N/A
  • NKTR $2.50
  • AVG Volume (30 Days)
  • MHLD 130.1K
  • NKTR 1.3M
  • Earning Date
  • MHLD 11-06-2024
  • NKTR 11-05-2024
  • Dividend Yield
  • MHLD N/A
  • NKTR N/A
  • EPS Growth
  • MHLD N/A
  • NKTR N/A
  • EPS
  • MHLD N/A
  • NKTR N/A
  • Revenue
  • MHLD $96,352,000.00
  • NKTR $93,157,000.00
  • Revenue This Year
  • MHLD N/A
  • NKTR N/A
  • Revenue Next Year
  • MHLD N/A
  • NKTR N/A
  • P/E Ratio
  • MHLD N/A
  • NKTR N/A
  • Revenue Growth
  • MHLD 38.31
  • NKTR 6.17
  • 52 Week Low
  • MHLD $1.19
  • NKTR $0.41
  • 52 Week High
  • MHLD $2.55
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • MHLD 57.55
  • NKTR 63.84
  • Support Level
  • MHLD $1.66
  • NKTR $1.27
  • Resistance Level
  • MHLD $1.76
  • NKTR $1.39
  • Average True Range (ATR)
  • MHLD 0.09
  • NKTR 0.09
  • MACD
  • MHLD 0.02
  • NKTR 0.01
  • Stochastic Oscillator
  • MHLD 91.67
  • NKTR 88.89

About MHLD Maiden Holdings Ltd.

Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commercial package, commercial auto, and extended warranty. The Diversified Reinsurance segment provides small and midsize regional and specialty insurers with reinsurance capital products. Its revenues also include fee income earned from both its GLS business and IIS business as well as income generated from its investment portfolio.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: